stethoscope supplier

Eko, a digital health company advancing heart and lung disease detection, today announced that, for the second consecutive year, it has won the Best Use of Artificial Intelligence in Healthcare award at MedTech Breakthrough's annual awards program. MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market. This year's program attracted more than 3,900 nominations from over 15 different countries throughout the world.

Eko's FDA-cleared and clinically proven AI algorithms can improve cardiac disease detection for all frontline clinicians without disrupting their workflow, creating more opportunities to detect heart disease early for more patients. Eko's line of smart stethoscopes analyzes heart sounds and ECG. In seconds, the algorithms* can detect heart murmurs and atrial fibrillation (AFib)** with comparable performance to human experts. This technology provides frontline healthcare professionals with a reliable, affordable, and scalable solution to screen for cardiovascular disease.

Heart disease is one of the most significant medical problems we have in America today, and with an ever-growing aging population, the incidence of heart failure and valvular heart disease will continue to increase, said Connor Landgraf, Co-founder and CEO of Eko. By putting disease screening technology in a device found on the neck or in the pocket of every healthcare professional, any patient interaction now becomes an opportunity to screen for cardiovascular disease. When signs of heart disease are detected early on, we can help expedite care decisions, decrease healthcare costs, and save lives.